Article info

Download PDFPDF
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Authors

  1. Correspondence to Dr Serena Fasano, Università degli Studi della Campania Luigi Vanvitelli, Napoli 80131, Italy; serena.fasano{at}unicampania.it
View Full Text

Citation

Fasano S, Riccardi A, Messiniti V, et al
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Publication history

  • Received May 28, 2019
  • Revised July 12, 2019
  • Accepted July 19, 2019
  • First published August 17, 2019.
Online issue publication 
November 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.